Eculizumab treatment for renal failure in a pediatric patient with COVID-19. uri icon

Overview

abstract

  • While there are increasing reports of acute kidney injury among hospitalized adults with COVID-19, there is still limited information on renal complications associated with COVID-19 in children. The cause of kidney involvement in COVID-19 is likely multifactorial, and appears to involve a complex process, including complement dysregulation and thrombotic microangiopathy. We present a pediatric case of COVID-19 and renal failure due to thombotic microangiopathy, successfully treated with eculizumab.

publication date

  • September 26, 2020

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • COVID-19
  • Kidney Failure, Chronic
  • Renal Dialysis
  • SARS-CoV-2

Identity

PubMed Central ID

  • PMC7519698

Scopus Document Identifier

  • 85091477226

Digital Object Identifier (DOI)

  • 10.1001/jama.2020.10374

PubMed ID

  • 32981025

Additional Document Info

volume

  • 33

issue

  • 6